Jianmin Pharmaceutical Group Co (SHSE:600976) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600976 Jianmin Pharmaceutical Group Co Ltd SHSE:600976
65 GF Score
Price ¥27.21
GF Value ¥39.48
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Jianmin Pharmaceutical Group Co  (SHSE:600976) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Related Terms


Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.94 2.85 3.51 2.13 1.66

Jianmin Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 1.98 1.65 1.63 1.21

SHSE:600976 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600976
65GF Score
Jianmin Pharmaceutical Group Co Ltd SHSE:600976
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jianmin Pharmaceutical Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Jianmin Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Jianmin Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.811/116.0564*116.0564
=4.811

Current CPI (Jun. 2026) = 116.0564.

Jianmin Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.714 102.400 4.209
201612 4.124 102.600 4.665
201703 3.781 103.200 4.252
201706 5.832 103.100 6.565
201709 4.175 104.100 4.655
201712 3.888 104.500 4.318
201803 3.215 105.300 3.543
201806 3.790 104.900 4.193
201809 3.370 106.600 3.669
201812 3.716 106.500 4.049
201903 3.358 107.700 3.619
201906 3.891 107.700 4.193
201909 4.670 109.800 4.936
201912 2.627 111.200 2.742
202003 2.871 112.300 2.967
202006 3.826 110.400 4.022
202009 3.777 111.700 3.924
202012 5.541 111.500 5.767
202103 5.495 112.662 5.661
202106 6.245 111.769 6.485
202109 5.339 112.215 5.522
202112 4.608 113.108 4.728
202203 6.026 114.335 6.117
202206 5.969 114.558 6.047
202209 6.388 115.339 6.428
202212 5.404 115.116 5.448
202303 6.616 115.116 6.670
202306 7.524 114.558 7.622
202309 6.257 115.339 6.296
202312 7.115 114.781 7.194
202403 6.341 115.227 6.387
202406 6.784 114.781 6.859
202409 5.655 115.785 5.668
202412 4.028 114.893 4.069
202503 5.815 115.116 5.863
202506 5.949 114.907 6.008
202509 4.872 115.471 4.897
202512 5.332 115.832 5.342
202603 5.692 116.303 5.680
202606 4.811 116.056 4.811

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Jianmin Pharmaceutical Group Co (SHSE:600976) Overvalued in 2026?

Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥27.21 is trading 31.1% below its estimated GF Value™ of ¥39.48. GuruFocus considers Jianmin Pharmaceutical Group Co to be Significantly Undervalued.

Key valuation signals for SHSE:600976:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥39.48 vs. price of ¥27.21 (31.1% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600976 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jianmin Pharmaceutical Group Co Business Description

Address No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
65GF Score

Get the complete analysis for SHSE:600976

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.21
Price
¥39.48
GF Value